Pulling SEC filings + quote and writing the call…

Immunocore Holdings plc
Next earnings Aug 5, 2026 (before open) · consensus $0.01 EPS, $113M rev
Last earnings +6.6% on 2026-05-06
Revenue grew 29.0% YoY; but unprofitable (net margin -8.9%).
Immunocore Holdings plc shows $400M in FY2025 revenue (+29.0% YoY), a -8.9% net margin, and -9.3% ROE.
Sources: SEC EDGAR (CIK 0001671927, latest 10-Q filed 2026-05-06) · EODHD · as of 6/25/2026, 2:22:10 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $4.08M | $174M | $249M | $310M | $400M |
| Gross profit | — | — | — | — | — |
| Operating income | -$175M | -$51.7M | -$59.6M | -$70.5M | -$45.4M |
| Net income | -$180M | -$52.5M | -$55.3M | -$51.1M | -$35.5M |
| Diluted EPS | -$4.24 | -$1.15 | -$1.13 | -$1.02 | -$0.71 |
| Net margin | -4414.6% | -30.1% | -22.2% | -16.5% | -8.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1079 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2026-02-18 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Sell | 11.5K @ $32.35 | $371K |
| 2026-02-17 | Jallal Bahija CHIEF EXECUTIVE OFFICER | Exercise | 23.8K |